Avet Pharmaceuticals Inc.
Brenda Lobb currently serves as a Compliance Investigator at Avet Pharmaceuticals since July 2021. Previously, Brenda held the position of Quality Systems Supervisor at Renaissance Lakewood, LLC from September 2018 to July 2021 and worked as a Quality Assurance Specialist at SOFIE as well as a Quality Assurance Manager at Zevacor from March 2016 to August 2018. Earlier experience includes a role as a Quality Control/Production Technician at IBA Molecular where responsibilities encompassed manufacturing and testing F18 pharmaceutical injections, operating cyclotron and synthesizer units, and conducting various Quality Control tests. Brenda's research background includes roles as a Research Assistant at Monmouth University, focusing on statistical consulting and analytical environmental chemistry. Brenda holds a Bachelor of Science degree in Chemistry and Biology from Monmouth University and an Associate of Science degree in Biology from Brookdale Community College.
Avet Pharmaceuticals Inc.
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.